Treatment of Spontaneous Coronary Artery Dissection (SCAD)
Conservative management is the first-line treatment for clinically stable SCAD patients, while revascularization should be reserved only for cases with ongoing ischemia, hemodynamic instability, or left main/proximal two-vessel involvement with critical flow limitation. 1, 2
Initial Management Approach
- Treatment strategy depends on clinical presentation, hemodynamic status, and coronary anatomy 1
- For clinically stable patients without high-risk features:
- Revascularization (PCI or CABG) should be considered only in:
Medical Therapy
- Beta-blockers:
- Antiplatelet therapy:
- Single antiplatelet therapy (SAPT) with aspirin is appropriate for conservatively managed patients without high-risk angiographic features 3, 5
- Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel should be used if PCI was performed, continuing for 12 months 3, 4
- Potent P2Y12 inhibitors (ticagrelor, prasugrel) should be avoided in SCAD patients 3
- Recent evidence suggests SAPT may be associated with better outcomes than DAPT in conservatively managed patients (6% vs 18.9% MACE rate) 5
- Blood pressure management:
- Aggressive anti-hypertensive therapy is recommended as hypertension is an independent predictor of recurrent SCAD 2
Medications to Avoid
- Fibrinolytic agents and anticoagulants should be avoided as they could worsen the intramural hematoma 3, 4
- Glycoprotein IIb/IIIa inhibitors are contraindicated 4
- Potent P2Y12 inhibitors (ticagrelor, prasugrel) should be avoided when possible 3
Revascularization Considerations
- PCI in SCAD has high failure rates (approximately 50%) and may worsen the dissection 1
- If revascularization is necessary:
- Intravascular imaging (OCT/IVUS) should only be used if revascularization decision has already been made, as it may trigger vessel closure 1
Long-term Management and Follow-up
- Long-term beta-blocker therapy should be continued to prevent recurrence 2, 3
- For patients with preserved left ventricular function, the optimal duration of beta-blocker therapy is being investigated in ongoing trials 6
- Consider coronary CT angiography for follow-up in patients with persistent or recurrent symptoms 2
- Evaluate for associated conditions, particularly fibromuscular dysplasia which occurs in up to 72% of SCAD cases 7
Management of Post-SCAD Chest Pain
- New acute ACS: Urgent evaluation following acute chest pain guidelines 1
- New or persistent stable angina: Evaluate with stress imaging (echo, CMR, nuclear perfusion) 1
- Atypical symptoms: Consider non-cardiac causes, address symptom triggers, and evaluate for coronary vasospasm or endothelial dysfunction 1